Rocacetrapib Uses, Dosage, Side Effects and more
Rocacetrapib is under investigation in clinical trial NCT02156544 (Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519).
Trade Name | Rocacetrapib |
Generic | Rocacetrapib |
Rocacetrapib Other Names | Rocacetrapib |
Type | |
Formula | C31H34F7NO3 |
Weight | Average: 601.606 Monoisotopic: 601.2426911 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |